B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics-Reference-Cited by-同舟云学术

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

Published:2021-09-23 Issue:1 Volume:81 Page:143-145
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Felten Renaud^ORCID,Duret Pierre-Marie,Bauer Elodie,Sedmak Nathanael,Djossou Julien H,Bensalem Massiva,Ardizzone Marc,Geoffroy Marion,Fan Angelique,Couderc Marion^ORCID,Salmon Jean Hugues,Messer Laurent,Javier Rose-Marie,Meyer Alain,Chatelus Emmanuel,Sordet Christelle,Pijnenburg Luc,Fort Jérémy,Rinagel Marina,Walther Julia,Fabre Cassandre,Arnaud Laurent^ORCID,Sibilia Jean,Meyer Nicolas,Berenbaum Francis^ORCID,Chary-Valckenaere isabelle,Soubrier Martin,Sellam Jérémie,Gottenberg Jacques-Eric^ORCID

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference4 articles.

1. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

2. Schulze-Koops H , Krueger K , Vallbracht I . Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab. Ann Rheum Dis 2020.

3. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

4. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study;Avouac;Lancet Rheumatol,2021

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 vaccination and infection status: a cross-sectional survey of patients with rheumatic diseases in China;Rheumatology International;2023-10-28

2. Systemic Lupus Erythematosus and COVID-19;Current Rheumatology Reports;2023-07-21

3. Neuromuscular Complications of COVID-19: Evidence from the Third Year of the Global Pandemic;Seminars in Neurology;2023-03-31

4. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study;The Lancet Rheumatology;2023-02

5. Outcomes of COVID-19 in people with rheumatic and musculoskeletal disease in Ireland over the first 2 years of the pandemic;Irish Journal of Medical Science (1971 -);2023-01-09